MUFG Americas Holdings Corp Sells 2,559 Shares of Clorox Co (CLX)

MUFG Americas Holdings Corp reduced its position in shares of Clorox Co (NYSE:CLX) by 36.7% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,418 shares of the company’s stock after selling 2,559 shares during the quarter. MUFG Americas Holdings Corp’s holdings in Clorox were worth $665,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CLX. Livingston Group Asset Management CO operating as Southport Capital Management bought a new position in shares of Clorox during the 3rd quarter valued at approximately $130,000. Ancora Advisors LLC bought a new position in shares of Clorox during the 3rd quarter valued at approximately $135,000. Fort L.P. bought a new position in shares of Clorox during the 2nd quarter valued at approximately $129,000. Legacy Advisors LLC bought a new position in shares of Clorox during the 3rd quarter valued at approximately $150,000. Finally, Cutler Group LP bought a new position in shares of Clorox during the 3rd quarter valued at approximately $162,000. Institutional investors and hedge funds own 77.96% of the company’s stock.

CLX has been the subject of a number of recent research reports. Wells Fargo & Co boosted their price objective on Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 17th. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research note on Wednesday, October 3rd. Deutsche Bank downgraded Clorox from a “hold” rating to a “sell” rating and set a $123.00 price objective for the company. in a research note on Wednesday, October 10th. Argus upgraded Clorox from a “hold” rating to a “buy” rating and set a $175.00 price objective for the company in a research note on Tuesday, September 25th. Finally, Citigroup boosted their price objective on Clorox from $149.00 to $153.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $146.00.

In other news, SVP Denise Garner sold 18,366 shares of the company’s stock in a transaction that occurred on Friday, December 7th. The stock was sold at an average price of $163.53, for a total transaction of $3,003,391.98. Following the sale, the senior vice president now directly owns 16,241 shares of the company’s stock, valued at approximately $2,655,890.73. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Jeff Baker sold 3,694 shares of the company’s stock in a transaction that occurred on Friday, December 7th. The stock was sold at an average price of $162.56, for a total value of $600,496.64. Following the sale, the chief accounting officer now directly owns 5,743 shares in the company, valued at $933,582.08. The disclosure for this sale can be found here. Insiders sold a total of 287,911 shares of company stock valued at $46,842,570 over the last 90 days. 1.40% of the stock is currently owned by corporate insiders.

CLX stock opened at $164.52 on Friday. Clorox Co has a 1-year low of $113.57 and a 1-year high of $167.70. The company has a quick ratio of 0.65, a current ratio of 1.07 and a debt-to-equity ratio of 3.38. The company has a market capitalization of $21.00 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 4.04 and a beta of 0.30.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.59 by $0.03. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The business had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the prior year, the company posted $1.46 EPS. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. On average, sell-side analysts expect that Clorox Co will post 6.31 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be paid a $0.96 dividend. The ex-dividend date is Tuesday, January 22nd. This represents a $3.84 annualized dividend and a yield of 2.33%. Clorox’s payout ratio is 61.34%.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.com-unik.info/2018/12/16/mufg-americas-holdings-corp-sells-2559-shares-of-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Different Types of Derivatives

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit